Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

Wave Life Sciences Ltd.

WVE · Nasdaq · CIK 0001631574 · Healthcare · Biotechnology

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

13 Form 4 transaction lines observed in the same window
4 sales · 9 option, withholding, award, gift or other lines

Last qualifying purchase2026-03-30 · Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. · $6.3M

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesModerate
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Wagner Heidi LDirector
○▼○
Rawcliffe AdrianDirector
▼○
TAKANASHI KENDirector
▼○
Tan Aik NaDirector
▼○
CORRIGAN MARKDirector
○
HENRY CHRISTIAN ODirector
○
● Purchase▼ Sale○ Other

Showing the six most active owners; 2 additional owner(s) remain in Form 4 evidence.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2026-03-30 · Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M..

Recent Form 4 activity

6Purchases
46Sales
40Other Form 4 lines
31SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING4 sale line(s) · context only
OTHER9 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
18,556,315
Previous report
17,637,783
Avg daily volume
3,255,781
Days to cover
5.7

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2026-03-30Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M.Purchase (P)Ordinary Shares971,091USD 6.50USD 6,312,092SEC filing ↗
2026-03-27Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M.Purchase (P)Ordinary Shares2,495,623USD 6.43USD 16,046,856SEC filing ↗
2026-03-26Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M.Purchase (P)Ordinary Shares5,305,782USD 6.08USD 32,265,431SEC filing ↗
2025-12-11GSK plcPurchase (P)Ordinary Shares1,470,000USD 19.00USD 27,930,000SEC filing ↗
2025-11-13Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M.Purchase (P)Ordinary Shares1,000USD 6.69USD 6,690SEC filing ↗
2024-09-27GSK plcPurchase (P)Ordinary Shares2,791,930USD 8.00USD 22,335,440SEC filing ↗
2023-12-11Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M.Purchase (P)Common Stock1,000,000USD 5.00USD 5,000,000SEC filing ↗
2023-12-11Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M.Purchase (P)Common Stock1,000,000USD 5.00USD 5,000,000SEC filing ↗
2023-12-07GSK plcPurchase (P)Ordinary Shares3,300,000USD 5.00USD 16,500,000SEC filing ↗
2022-06-16Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M.Purchase (P)Ordinary Shares9,480,052USD 2.15USD 20,382,112SEC filing ↗

Form 4 evidence

92 transaction lines in the latest 365-day window; 198 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-05Wagner Heidi LAward / grant (A)Common Stock10,700USD 0.00USD 0SEC filing ↗
2026-10-05Verdine Gregory L.Award / grant (A)Common Stock10,700USD 0.00USD 0SEC filing ↗
2026-10-05Tan Aik NaAward / grant (A)Common Stock10,700USD 0.00USD 0SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-05Wagner Heidi LAward / grant (A)Common Stock10,700USD 0.00USD 0SEC filing ↗
2026-10-05Verdine Gregory L.Award / grant (A)Common Stock10,700USD 0.00USD 0SEC filing ↗
2026-10-05Tan Aik NaAward / grant (A)Common Stock10,700USD 0.00USD 0SEC filing ↗
2026-10-05TAKANASHI KENAward / grant (A)Common Stock10,700USD 0.00USD 0SEC filing ↗
2026-10-05Rawcliffe AdrianAward / grant (A)Common Stock10,700USD 0.00USD 0SEC filing ↗
2026-10-05Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M.Award / grant (A)Common Stock10,700USD 0.00USD 0SEC filing ↗
2026-10-05HENRY CHRISTIAN OAward / grant (A)Common Stock10,700USD 0.00USD 0SEC filing ↗
2026-10-05CORRIGAN MARKAward / grant (A)Common Stock10,700USD 0.00USD 0SEC filing ↗
2026-08-12Rawcliffe AdrianSale (S)Common Stock12,700USD 5.29USD 67,183SEC filing ↗
2026-08-11Wagner Heidi LSale (S)Common Stock7,000USD 6.01USD 42,070SEC filing ↗
2026-08-11Wagner Heidi LOption exercise / conversion (M)Common Stock7,000USD 5.97USD 41,790SEC filing ↗
2026-08-11Tan Aik NaSale (S)Common Stock432USD 6.01USD 2,596SEC filing ↗
2026-08-11TAKANASHI KENSale (S)Common Stock3,864USD 6.01USD 23,223SEC filing ↗
2026-03-30Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M.Purchase (P)Ordinary Shares971,091USD 6.50USD 6,312,092SEC filing ↗
2026-03-27Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M.Purchase (P)Ordinary Shares2,495,623USD 6.43USD 16,046,856SEC filing ↗
2026-03-26Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M.Purchase (P)Ordinary Shares5,305,782USD 6.08USD 32,265,431SEC filing ↗
2026-03-23TAKANASHI KENC (C)Ordinary Shares3,901,348USD 0.00USD 0SEC filing ↗
2026-02-26Francis ChrisSale (S)Ordinary Shares33,194USD 15.05USD 499,521SEC filing ↗
2026-02-26Francis ChrisOption exercise / conversion (M)Ordinary Shares33,194USD 4.28USD 141,920SEC filing ↗
2026-02-09Vargeese ChandraSale (S)Ordinary Shares3,228USD 13.45USD 43,417SEC filing ↗
2026-02-09Moran KyleSale (S)Ordinary Shares3,588USD 13.45USD 48,259SEC filing ↗
2026-02-09Francis ChrisSale (S)Ordinary Shares1,883USD 13.45USD 25,326SEC filing ↗
2026-02-09BOLNO PAULSale (S)Ordinary Shares10,480USD 13.45USD 140,956SEC filing ↗
2026-02-05Vargeese ChandraAward / grant (A)Ordinary Shares45,625USD 0.00USD 0SEC filing ↗
2026-02-05Moran KyleAward / grant (A)Ordinary Shares45,625USD 0.00USD 0SEC filing ↗
2026-02-05Francis ChrisAward / grant (A)Ordinary Shares38,750USD 0.00USD 0SEC filing ↗
2026-02-05BOLNO PAULAward / grant (A)Ordinary Shares165,000USD 0.00USD 0SEC filing ↗
2026-01-02Francis ChrisSale (S)Ordinary Shares9,375USD 16.03USD 150,260SEC filing ↗
2026-01-02Francis ChrisOption exercise / conversion (M)Ordinary Shares9,375USD 3.14USD 29,438SEC filing ↗
2025-12-11GSK plcPurchase (P)Ordinary Shares1,470,000USD 19.00USD 27,930,000SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerWVE
CIK0001631574
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNasdaq

Data coverage

Local Form 4 history198 transaction lines from 2020-02-03 to 2026-10-05
11 P purchase lines · 97 S sale lines · 90 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.